Global longitudinal strain is superior to ejection fraction for detecting myocardial dysfunction in end-stage renal disease with hyperparathyroidism

Table 3 Echocardiographic population variables control, end-stage renal disease on hemodialysis and end-stage renal disease on peritoneal dialysis

Variables	Control	ESRD-HD	ESRD-PD	P value
LVEF	60.75 ± 1.30	63.5 ± 10.36	61.8 ± 11.19	NS
GLS (%)	21 ± 0.58a,c	13 ± 0.72	12 ± 1.83	< 0.0001
LAV (mL/m2)	33.07 ± 0.22a,c	26.49 ± 1.4	25.73 ± 1.57	< 0.0001
E/A ratio	1.25 ± 0.03a,c	1.05 ± 0.06	0.91 ± 0.05	< 0.0001
E/é ratio	5.38 ± 0.18a,c	11.62 ± 0.96	12.22 ± 1.13	< 0.0001
E (cm/s)	60.39 ± 1.71a,c	80.19 ± 6.26	81.29 ± 6.97	< 0.0001
Lateral e’ (cm/s)	13.44 ± 0.36a,c	8.33 ± 0.43	7.49 ± 0.16	< 0.0001
Septal é (cm/s)	10.85 ± 0.35a,c	6.18 ± 0.24	6.49 ± 0.23	< 0.0001
TRV (m/s)	2.21 ± 0.02a,c	2.94 ± 0.08	2.80 ± 0.07	< 0.0001
LVMI (g /m2)	70.65 ± 2.11a,c	130.2 ± 6.24	127.5 ± 6.55	< 0.0001
RWT	0.39 ± 0.016a,c	0.51 ± 0.01	0.51 ± 0.02	< 0.0001

^aP < 0.05, control vs ESRD-HD.

^cP < 0.05, control vs ESRD-PD.

The data represents mean SD. ANOVA followed by Tukey test was performed and was considered significant. ESRD: End-stage renal disease; ESRD-HD: ESRD on hemodialysis; ESRD-PD: ESRD on peritoneal dialysis; LVEF: Left ventricular ejection fraction; GLS: Global longitudinal strain; LAV: Left atrial volume; TRV: Tricuspid regurgitation velocity; LVMI: LV mass index; NS: Not significant; RWT: Relative wall thickness.